PubMed Health⌕ Search

Biomedical subjects

J Schur

Publications and source records attributed to J Schur.

4 recordsLinked to original sources
PubMed1997

Role of quantitative cultures and microscopic examinations of endotracheal aspirates in the diagnosis of pulmonary infections in ventilated patients.

Endotracheal aspirates (EA) from 20 intubated patients in a surgical intensive care unit (mean ventilation time/patient = 16.5 days) were investigated serially by performing quantitative cultures using growth of 10(5) cfu/mL as a cut-off point. Microscopic examinations were made using Giemsa's stain for polymorphonuclear neutrophils (PMN). The spectrum of pathogens encountered was determined and compared with clinical data to distinguish colonization from infection of the lower respiratory tract. Out of 301 EA cultures, 156 (51.8%) were positive and 145 (48.2%) were below the cut-off point. Counts of PMN were significantly higher in samples which gave positive cultures. Seventy-five different bacterial strains were isolated (64% were Gram-negative bacilli). Seventeen patients (85%) were colonized with Gram-negative bacteria. Nine patients (45%) developed nosocomial pneumonia (NP), five (25%) had no signs of pneumonia, and six (30%) had an uncertain status. Main causative agents for NP were Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus. Quantitative EA cultures had a sensitivity of 81.5%, a specificity of 64.8%, a positive predictive value of 55% and a negative predictive value of 87%. Our results suggest that EA quantitative cultures (cut-off value 10(5) cfu/mL), species identification and microscopic examination of EA may help to differentiate tracheobronchial colonization and infection, especially when bronchoscopic techniques are not available.

Adult↗
PubMed1997

Prevalence of antibody to Trypanosoma cruzi in three populations in Belize.

Cross-sectional studies were conducted to determine the prevalence of antibody to Trypanosoma cruzi, the agent of Chagas' disease among three populations in Belize. Specimens were tested using a second-generation enzyme-linked immunoassay (EIA). Confirmatory testing with three single-antigen EIAs and a radioimmunoprecipitation assay (RIPA) were performed. Five (0.5%) of 962 blood donors at the Belize City Hospital were reactive including four (6%) of 65 donors from countries known to be endemic for Chagas' disease and one (0.1%) of 861 from Belize (P < 0.001). Among 467 healthy members of the Belize Defense Force, none were reactive. The third group included workers and families primarily from other Central American countries living on a banana plantation in a rural area of the country. Twenty-seven (6.1%) of 442 sera were reactive. The prevalence was 5.3% of 75 < 15 years of age, 4.2% of 236 15-34 years of age, and 9.7% of 124 > or = 35 years of age (P = 0.11, by chi-square for trend). The prevalence was similar in males (6.7% of 280) and females (5.8% of 154). The prevalence of those born in Belize (4 of 56, 7.1%) was similar with that of those born in El Salvador (9 of 110, 8.2%), Guatemala (6 of 117, 5.1%), and Honduras (8 of 129, 6.2%). Of the four persons with reactive sera who were born in Belize, the immigrant mother of one was also reactive, suggesting possible congenital transmission. Among 31 sera repeatedly reactive by EIA to T. cruzi that were further studied, 22 (71%) were reactive by at least two of three single-antigen confirmatory EIAs and 29 (94%) by RIPA. Additional studies should focus on the epidemiology of T. cruzi and ways to reduce risk of transfusion-related infections in Belize.

Adolescent↗